Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Nocturia - Overview
Nocturia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Nocturia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Nocturia - Companies Involved in Therapeutics Development
Ferring Intertiol Center SA
Ferring Research Institute Inc
Tacurion Pharma Inc
Wellesley Pharmaceuticals LLC
Nocturia - Drug Profiles
(acetaminophen + ibuprofen) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASP-7035 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
desmopressin acetate ODT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FE-201836 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptide 1 to Agonise Vasopressin V2 Receptor for Nocturia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptide to Agonise Vasopressin V2 Receptor for Nocturia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Nocturia - Dormant Projects
Nocturia - Discontinued Products
Nocturia - Product Development Milestones
Featured News & Press Releases
Nov 09, 2018: NOCDUR (desmopressin acetate) sublingual tablets now available by prescription in US for treatment of nocturia due to nocturl polyuria
Aug 08, 2017: Ferring Pharmaceuticals: The Scottish Medicines Consortium Approves Use of NOQDIR (oral lyophilisate desmopressin), the First Licensed Treatment for Nocturia due to Idiopathic Nocturl Polyuria in Adults
Aug 07, 2017: Noqdir is accepted for restricted use within NHS Scotland
Feb 13, 2017: Scottish Medicines Consortium Rejects Noqdir For Use Within NHS Scotland
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Nocturia, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Nocturia, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Nocturia - Pipeline by Ferring International Center SA, 2021
Nocturia - Pipeline by Ferring Research Institute Inc, 2021
Nocturia - Pipeline by Tacurion Pharma Inc, 2021
Nocturia - Pipeline by Wellesley Pharmaceuticals LLC, 2021
Nocturia - Dormant Projects, 2021
Nocturia - Discontinued Products, 2021